Abstract
Background. Unlike solid organ transplantation, upper limb allotransplantation outcomes, especially functional results, can only be fully assessed in the long-term. Current bionic prostheses have significant disadvantages and cannot provide patients with a high quality of life. Objective. To assess the long-term (>1 year) outcome of the first successful hand allotransplantation in Russia performed on April 20, 2025. Patient and methods. A 52-year-old man who had lost his right forearm and hand to a mine-blast injury, underwent right forearm-hand allotransplantation in 2022 under triple immunosuppression (tacrolimus, mycophenolate mofetil, prednisolone) with thymoglobulin induction. Long-term outcome was assessed using photographic and video documentation, ultrasound, radiography, CT angiography, needle biopsy, and histology examination. Results. The patient returned to work after 3 months. By more than one 1 year, the transplanted hand was fully usable in daily life, work, and sports, with complete restoration of his original handwriting and of superficial and deep sensitivity. Laboratory and instrumental examinations after 1 year confirmed the absence of complications and the patient's healthy status. Conclusion. The long-term outcome of the first hand allotransplantation in Russia in terms of motor function, sensitivity, and overall health is one of the most successful in the world, supporting further implementation of the method for treating patients with the loss of one or both hands.